Mechanisms behind growth of castration-resistant prostate cancer bone metastases

Background: The first-line treatment for patients with advanced prostate cancer (PC) is androgen deprivation therapy. This therapy is initially effective, but after some time tumors relapse, predominantly within the bone, and are then termed castration-resistant prostate cancer (CRPC). The majority...

Full description

Bibliographic Details
Main Author: Jernberg, Emma
Format: Doctoral Thesis
Language:English
Published: Umeå universitet, Patologi 2013
Subjects:
Online Access:http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-83956
http://nbn-resolving.de/urn:isbn:978-91-7459-775-2

Similar Items